Leadership Team
Share this page:
Scott Boyer
Founder and President
Scott has almost three decades of experience in the pharmaceutical industry and has led the sales and marketing efforts for numerous branded drugs for Abbott and Bristol-Myers Squibb. Scott has a passion for creating a pharmaceutical model that provides medications to all patients. His education includes a B.S. in Business Administration and Management from Morningside College.
Mary Dunham
Chief Operating Officer
Mary has 25+ years of experience at large pharmaceutical companies including Schering-Plough, Merck, Bayer, and Sanofi. With the passion of a life-long learner, Mary’s career includes leadership positions in supply chain, portfolio and pipeline management, sales/trade marketing, and finance. She holds a B.S. degree in Business Administration majoring in Finance and Information Technology from Marquette University.
Bruce Duncan
Chief Financial Officer
Bruce has more than thirty years of experience at the C-level in accounting and tax management, including a decade at a Big 4 accounting firm and a decade managing the tax department of a Fortune 100 company. Bruce was also the Sr. Vice President of Finance at a capital management firm that grew to more than $50 billion during his tenure. He is a Certified Public Accountant and has a law degree from Case Western.
Dr. Paul Sudhakar
Director of Scientific Affairs
Paul has been actively involved in pharmaceutical consulting, including project development and support activities involving preclinical, clinical, bioequivalence studies, chemistry/manufacturing controls and filing/approval of drug applications for more than three decades. Paul consults with many pharmaceutical companies around the globe to help them prepare for FDA review on drug and biologic manufacturing.
Mark Petersen
National Business Director
Mark has over 30 years of experience in the Pharmaceutical industry primarily in Sales Leadership. His experience as a Director of Communication and Coordination with Astellas Pharma has provided him great understanding and experience of how to build and structure sales organizations for optimal performance. Mark earned an Executive MBA in Pharmaceutical Marketing from St. Joseph University.
Julie G. Anderson
Senior Director of Marketing
Julie brings over 40 years of clinical and commercialization experience to OWP. She has served in the pharmaceutical and medical device industries in sales, marketing, medical education, and advertising. Her therapeutic expertise spans a multitude of conditions in primary, specialized, and critical care. Julie has a BSN from the University of North Carolina at Chapel Hill and a Masters of Management from the JL Kellogg Graduate School of Management at Northwestern University.
Scott Boyer
Founder and President
Scott has almost three decades of experience in the pharmaceutical industry and has led the sales and marketing efforts for numerous branded drugs for Abbott and Bristol-Myers Squibb. Scott has a passion for creating a pharmaceutical model that provides medications to all patients. His education includes a B.S. in Business Administration and Management from Morningside College.
Mary Dunham
Chief Operating Officer
Mary has 25+ years of experience at large pharmaceutical companies including Schering-Plough, Merck, Bayer, and Sanofi. With the passion of a life-long learner, Mary’s career includes leadership positions in supply chain, portfolio and pipeline management, sales/trade marketing, and finance. She holds a B.S. degree in Business Administration majoring in Finance and Information Technology from Marquette University.
Bruce Duncan
Chief Financial Officer
Bruce has more than thirty years of experience at the C-level in accounting and tax management, including a decade at a Big 4 accounting firm and a decade managing the tax department of a Fortune 100 company. Bruce was also the Sr. Vice President of Finance at a capital management firm that grew to more than $50 billion during his tenure. He is a Certified Public Accountant and has a law degree from Case Western.
Dr. Paul Sudhakar
Director of Scientific Affairs
Paul has been actively involved in pharmaceutical consulting, including project development and support activities involving preclinical, clinical, bioequivalence studies, chemistry/manufacturing controls and filing/approval of drug applications for more than three decades. Paul consults with many pharmaceutical companies around the globe to help them prepare for FDA review on drug and biologic manufacturing.
Mark Petersen
National Business Director
Mark has over 30 years of experience in the Pharmaceutical industry primarily in Sales Leadership. His experience as a Director of Communication and Coordination with Astellas Pharma has provided him great understanding and experience of how to build and structure sales organizations for optimal performance. Mark earned an Executive MBA in Pharmaceutical Marketing from St. Joseph University.
Julie G. Anderson
Senior Director of Marketing
Julie brings over 40 years of clinical and commercialization experience to OWP. She has served in the pharmaceutical and medical device industries in sales, marketing, medical education, and advertising. Her therapeutic expertise spans a multitude of conditions in primary, specialized, and critical care. Julie has a BSN from the University of North Carolina at Chapel Hill and a Masters of Management from the JL Kellogg Graduate School of Management at Northwestern University.